Related Experiment Video
Updated: Jan 11, 2026

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
A Review of Indications and Guidelines of Chronic Total Occlusion Revascularization
Spas Kotev1, Farhad Sami1, Boniface Malangu1
1Department of Cardiology, University of Iowa Health Care, Iowa City, Iowa.
Insights
Percutaneous coronary intervention for chronic total occlusion (CTO PCI) effectively relieves angina and improves quality of life in coronary artery disease patients. While successful, long-term benefits on mortality and cardiac function require further investigation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Chronic total occlusion (CTO) affects 18-30% of coronary artery disease patients.
- CTO is associated with refractory angina, impaired left ventricular function, and arrhythmias.
Purpose of the Study:
- To review indications, evidence, and guidelines for CTO revascularization, primarily percutaneous coronary intervention (PCI).
- To provide clinicians a framework for managing CTO, balancing evidence and patient care.
Main Methods:
- Synthesis of current literature on CTO revascularization.
- Review of randomized controlled trials and clinical guidelines (ACC/AHA/SCAI, ESC/EACTS).
Main Results:
- CTO PCI demonstrates high success rates (>85%) in experienced centers.
- RCTs indicate improved symptom relief and quality of life post-CTO PCI.
- Benefits regarding mortality or ventricular function remain unproven.
Conclusions:
- Current guidelines recommend CTO PCI for refractory angina, stressing operator expertise and shared decision-making.
- Ongoing research and trials are needed to address controversies in prognostic benefits and patient selection.
Abstract:
Chronic total occlusion (CTO), affecting 18 to 30% of coronary artery disease patients undergoing angiography, is linked to refractory angina, reduced left ventricular function, and increased arrhythmia risk. This article synthesizes indications, evidence, and guidelines for CTO revascularization, focusing on percutaneous coronary intervention (PCI). CTO PCI achieves over 85% success rates in expert hands, with randomized controlled trials showing improved symptom relief and quality of life, though mortality or ventricular function benefits remain unproven. The 2021 ACC/AHA/SCAI and 2018 ESC/EACTS guidelines recommend CTO PCI for refractory angina, emphasizing operator expertise and shared decision-making. Controversies persist regarding prognostic benefits and patient selection. Ongoing trials aim to clarify these issues. This review equips clinicians with a framework to navigate CTO management, balancing evidence and patient-centered care.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis III: Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome III: Diagnostic Studies

